FDAnews
www.fdanews.com/articles/144998-glaxo-joins-j-amp-j-in-200-million-fund-with-index-ventures

Glaxo Joins J&J in $200 Million Fund With Index Ventures

March 21, 2012
GlaxoSmithKline and Johnson & Johnson are forming a $200 million fund with index ventures to invest in early-stage biotechnology companies, a move that may entice venture capitalists back to the industry.
Bloomberg